EGFR is mainly stimulated through protein overexpression in colorectal adenocarcinoma, whereas in adenocarcinoma of the lung it is mainly activated through hyper-activating point mutations occurring in its tyrosine kinase domain. Here, EGFR is linked to colorectal adenocarcinoma.